These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9631067)

  • 1. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
    Flanagan WM; Su LL; Wagner RW
    Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
    Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
    Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
    Hung WC; Huang JS; Chuang LY
    Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II.
    Fluiter K; ten Asbroek AL; van Groenigen M; Nooij M; Aalders MC; Baas F
    Cancer Res; 2002 Apr; 62(7):2024-8. PubMed ID: 11929820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression.
    Morris MC; Chaloin L; Choob M; Archdeacon J; Heitz F; Divita G
    Gene Ther; 2004 May; 11(9):757-64. PubMed ID: 14961071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.
    Thompson ME; Jensen RA; Obermiller PS; Page DL; Holt JT
    Nat Genet; 1995 Apr; 9(4):444-50. PubMed ID: 7795653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
    Roh H; Pippin J; Boswell C; Drebin JA
    J Surg Res; 1998 Jun; 77(1):85-90. PubMed ID: 9698539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
    Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
    J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells.
    Barascu A; Besson P; Le Floch O; Bougnoux P; Jourdan ML
    Int J Biochem Cell Biol; 2006 Feb; 38(2):196-208. PubMed ID: 16194618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
    J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.
    Flanagan WM; Kothavale A; Wagner RW
    Nucleic Acids Res; 1996 Aug; 24(15):2936-41. PubMed ID: 8760877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
    Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
    Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.
    Swarbrick A; Akerfeldt MC; Lee CS; Sergio CM; Caldon CE; Hunter LJ; Sutherland RL; Musgrove EA
    Oncogene; 2005 Jan; 24(3):381-9. PubMed ID: 15489884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells.
    Dan S; Yamori T
    Biochem Biophys Res Commun; 2001 Jan; 280(3):861-7. PubMed ID: 11162602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.